晚期口咽癌与下咽癌手术治疗生存获益的回顾性分析
基于美国国家癌症数据库,纳入2004至2009年临床III/IVA期口咽癌1603例和下咽癌1512例,随访至2012年。分析显示31.4%的口咽癌和42.2%的下咽癌患者以手术为主要治疗,在控制潜在混杂因素后,原发手术与更高生存率相关。作者推荐手术作为晚期口咽癌和下咽癌的一线治疗选择。
要点
- 晚期口咽癌和下咽癌中,分别有31.4%和42.2%以手术为主要治疗。
- 控制混杂因素后,原发手术与更高的生存率相关。
- 作者推荐手术应被视为晚期口咽癌和下咽癌的一线治疗。
核心结论
- 晚期口咽癌和下咽癌患者接受原发手术与更高的生存率相关,作者推荐手术作为一线治疗选择。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库,纳入2004至2009年临床III/IVA期口咽癌1603例和下咽癌1512例,随访至2012年,采用Kaplan-Meier生存分析和Cox回归。
主要发现
- 31.4%的晚期口咽癌患者和42.2%的下咽癌患者以手术为主要治疗。
- 在控制潜在混杂因素后,晚期口咽癌和下咽癌接受原发手术与更高的生存率相关。
临床怎么用
- 在晚期口咽癌和下咽癌的治疗决策中,应考虑将手术作为一线治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck cancer is increasingly being managed through nonsurgical approaches. Evidence comes from studies that have mainly examined patients with laryngeal cancer. Few studies, with limited sample size, have focused on the comparative outcomes of surgical and nonsurgical approaches in patients with advanced oropharyngeal or hypopharyngeal cancer. METHODS: Using a national cancer database, we identified 1603 and 1512 patients with clinical stage III/IVA oropharyngeal and hypopharyngeal cancer, respectively, treated between 2004 and 2009. The study cohort was followed until 2012, and analyzed through Kaplan-Meier survival analysis and Cox regression. RESULTS: Overall, 31.4% of patients with advanced oropharyngeal cancer and 42.2% of patients with hypopharyngeal cancer received surgery as their primary treatment. Receiving primary surgery for advanced oropharyngeal and hypopharyngeal cancer was associated with higher survival rates after controlling for potential confounders. CONCLUSION: We recommend that surgery be considered a first-line treatment for advanced oropharyngeal and hypopharyngeal cancers.
引用
- Cheng CT, Lin CY, Hung-Chun Cheng S, et al. Survival benefit of surgical approach for advanced oropharyngeal and hypopharyngeal cancer: A retrospective analysis. Head Neck. 2017. PMID: 28691358. doi:10.1002/hed.24869
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。